Treatment of active secondary progressive multiple sclerosis with treosulfan
- 20 April 2007
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Neurologie
- Vol. 254 (7) , 884-889
- https://doi.org/10.1007/s00415-006-0459-6
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Myeloablative and immunosuppressive properties of treosulfan in miceExperimental Hematology, 2006
- Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantroneZeitschrift für Neurologie, 2005
- Action of treosulfan in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis and human lymphocytesJournal of Neuroimmunology, 2003
- Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosisAnnals of Neurology, 2001
- The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessmentMultiple Sclerosis Journal, 1999
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Rating neurologic impairment in multiple sclerosisNeurology, 1983